MAJA MATWIEJCZUK: Open Payments
NPI 1093276750 · ENFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,216 in 190 payments from 21 companies in 2025. Trend: 2023 $3,140 · 2024 $2,140 · 2025 $3,216
Food & beverage: $3,121Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $564 |
| E.R. Squibb & Sons, L.L.C. | 17 | $368 |
| Janssen Biotech, Inc. | 21 | $316 |
| UCB, Inc. | 26 | $285 |
| Arcutis Biotherapeutics, Inc. | 20 | $242 |
| Incyte Corporation | 12 | $213 |
| GENZYME CORPORATION | 7 | $195 |
| Amgen Inc. | 7 | $157 |
| PFIZER INC. | 9 | $146 |
| Lilly USA, LLC | 10 | $142 |
Products named: Sotyktu, DUPIXENT, TREMFYA, RINVOQ, Bimzelx, SKYRIZI, Zoryve, OPZELURA.
Industry payments across CT — which companies pay providers there.
